华润医药：华润三九中期股东应占净利润18.15亿元，同比减少24.31%

Group 1 - The core viewpoint of the article is that China Resources Pharmaceutical (03320) has reported the unaudited financial performance of its subsidiary China Resources Sanjiu (000999) for the six months ending June 30, 2025, showing a mixed performance in revenue and profit [1] Group 2 - The total operating revenue for the company reached RMB 14.81 billion, representing a year-on-year increase of 4.99% [1] - The net profit attributable to shareholders was RMB 1.815 billion, which reflects a year-on-year decrease of 24.31% [1] - The basic earnings per share stood at RMB 1.09 [1]